Eliem Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -56,372 | -3,005 | -5,122 | -5,001 |
EBIT | -6,010 | -5,165 | -9,780 | |
Net Income | -54,889 | -1,697 | -3,641 | -3,968 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -667 | -1,819 | -947 | 3,490 |
Cash | 223,140 | 105,031 | 93,112 | 57,353 |
Basic Shares | 30,349 | 27,638 | 27,699 | 27,071 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -13,653 | -43,651 | -35,502 | -2,866 |
EBIT | -35,119 | -88,786 | -71,174 | -14,633 |
Net Income | -35,119 | -45,353 | -47,480 | -11,510 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -2,929 | 26,190 | ||
Free Cash Flow | -20,599 | -37,369 | -36,072 | -14,098 |
Cash | 93,112 | 43,585 | 46,922 | 20,487 |
Basic Shares | 26,987 | 26,311 | 26,235 | 26,318 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$1.80 |
2024-03-31 | -$0.06 |
2023-12-31 | -$0.13 |
2023-09-30 | -$0.14 |
